ANTIDEPRESSANTS AND ANXIOLYTICS - THEIR INTERACTION ON VIGILANCE

被引:0
|
作者
ANTONIJOAN, RM
BARBANOJ, MJ
ANDERER, P
TORRENT, J
JANE, F
SALETU, B
机构
[1] UNIV AUTONOMA BARCELONA,DEPT PHARMACOL & PSYCHIAT,BARCELONA,SPAIN
[2] UNIV VIENNA,DEPT PSYCHIAT,PHARMACOPSYCHIAT SECT,A-1010 VIENNA,AUSTRIA
关键词
D O I
暂无
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
引用
收藏
页码:248 / 248
页数:1
相关论文
共 50 条
  • [41] Coment on Campagne "Fact: Antidepressants and anxiolytics are not safe during pregnancy"
    Einarson, Adrienne
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 142 (02) : 163 - 163
  • [42] Use of antidepressants and anxiolytics among patients with chronic diseases in the Netherlands
    van den Heuvel, Jan Maurik
    Pelgrim, Charlotte E.
    Kraneveld, Aletta D.
    van der Zee, Anke-Hilse Maitland
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 276 - 276
  • [43] Gender differences in the use of anxiolytics and antidepressants: a population based study
    Van der Heyden, J. H. A.
    Gisle, L.
    Hesse, E.
    Demarest, S.
    Drieskens, S.
    Tafforeau, J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (11) : 1101 - 1110
  • [44] 5-HT1A partial agonists as anxiolytics and antidepressants
    Sprouse, J
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S35 - S35
  • [45] Inhibitory Actions of Antidepressants, Hypnotics, and Anxiolytics on Recombinant Human Acetylcholinesterase Activity
    Obara, Keisuke
    Mori, Haruka
    Ihara, Suzune
    Yoshioka, Kento
    Tanaka, Yoshio
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (01) : 328 - 333
  • [46] VARIATION IN PRESCRIBING OF HYPNOTICS, ANXIOLYTICS AND ANTIDEPRESSANTS BETWEEN 61 GENERAL PRACTICES
    PHAROAH, PDP
    MELZER, D
    BRITISH JOURNAL OF GENERAL PRACTICE, 1995, 45 (400): : 595 - 599
  • [47] CRF1 receptor antagonists as novel putative antidepressants and anxiolytics
    Nemeroff, CB
    Owens, MJ
    Skelton, K
    Guttman, D
    Winslow, JT
    Plotsky, PM
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 64S - 64S
  • [48] The brain renin-angiotensin system: A target for novel antidepressants and anxiolytics
    Gard, PR
    DRUG DEVELOPMENT RESEARCH, 2005, 65 (04) : 270 - 277
  • [49] Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia
    Kopecek, Miloslav
    Bares, Martin
    Horacek, Jiri
    Mohr, Pavel
    NEUROENDOCRINOLOGY LETTERS, 2006, 27 (06) : 803 - 806
  • [50] Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
    Tiger, Mikael
    Castelpietra, Giulio
    Wesselhoeft, Rikke
    Lundberg, Johan
    Reutfors, Johan
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01)